Kim, Y. 2009. Zanolimumab (Humax-CD4), a fully human monoclonal antibody with significant clinical responses in cutaneous T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports). 3, 1 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v3i1.540.